1. Benefits of supplementation with microbial omega-3 fatty acids on human health and the current market scenario for fish-free omega-3 fatty acid
- Author
-
Dimitra Karageorgou, Ulrika Rova, Paul Christakopoulos, Petros Katapodis, Leonidas Matsakas, and Alok Patel
- Subjects
Omega-3 ,Näringslära ,Nutrition and Dietetics ,Bioprocessteknik ,Human health ,PUFAs ,Bioprocess Technology ,Nutraceutical fatty acids ,oleaginous microalgae ,Omega-6 ,Food Science ,Biotechnology - Abstract
BackgroundGrowing evidence points to a link between specific fatty acids ingested through the diet and human health. Chain length, saturation degree, and position of double bonds in fatty acids determine their effect in humans. Omega-3 and omega-6 fatty acids have been recognized for their contribution to the prevention and/or treatment of diabetes, cancer, visual impairment, cardiovascular diseases, as well as neurological and musculoskeletal disorders. Scope and approachHumans cannot synthesize these fatty acids in sufficient amounts and need to absorb them through the diet. Oleaginous microalgae constitute a promising, sustainable source of such fatty acids, as they can accumulate up to 85% of lipids on a cell dry weight basis. Key findings and conclusionsThe present review summarizes the potential of oleaginous microalgae as a convenient, economical, and sustainable source of polyunsaturated fatty acids, and explores their beneficial role in human health. The growing prevalence of cardiovascular diseases and changing dietary preferences are driving the increasing demand for microbial omega-3 fatty acids. Following the COVID-19 pandemic, the importance of a healthy immune system has further strengthened the market for omega-3 fatty acids. Validerad;2023;Nivå 2;2023-05-12 (hanlid);Funder: Hellenic Foundation for Research and Innovation (HFRI) and the General Secretariat for Research and Technology (GSRT) (1137) Green and sustainable approach to valorise high saline and oily fish processing effluents for production of nutraceuticals Boosting the squalene content in thraustochytrids by genetic engineering using CRISPR–Cas9 System to replace shark-based squalene as an adjuvant for COVID 2019 vaccine
- Published
- 2023
- Full Text
- View/download PDF